XML 50 R28.htm IDEA: XBRL DOCUMENT v3.4.0.3
Fair Value Measurements (Tables)
3 Months Ended
Apr. 03, 2016
Fair Value Disclosures [Abstract]  
Summary of assets and liabilities measured and recorded at fair value on a recurring basis
The following table summarizes the Company's assets and liabilities measured and recorded at fair value on a recurring basis as of April 3, 2016 and January 3, 2016:
 
 
April 3, 2016
 
January 3, 2016
(In thousands)
 
Total
 
Level 1
 
Level 2
 
Total
 
Level 1
 
Level 2
Assets
 
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents1:
 
 
 
 
 
 
 
 
 
 
 
 
Money market funds
 
$
160,859

 
$
160,859

 
$

 
$
540,000

 
$
540,000

 
$

Prepaid expenses and other current assets:
 
 
 
 
 
 
 
 
 
 
 
 
Derivative financial instruments (Note 11)
 
5,819

 

 
5,819

 
8,734

 

 
8,734

Total assets
 
$
166,678

 
$
160,859

 
$
5,819

 
$
548,734

 
$
540,000


$
8,734

Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
Accrued liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
Derivative financial instruments (Note 11)
 
10,811

 

 
10,811

 
2,316

 

 
2,316

Other long-term liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
Derivative financial instruments (Note 11)
 
948

 

 
948

 
1,033

 

 
1,033

Total liabilities
 
$
11,759

 
$

 
$
11,759

 
$
3,349

 
$

 
$
3,349

1 
The Company's cash equivalents consist of money market fund instruments and commercial paper that are classified as available-for-sale and are highly liquid investments with original maturities of 90 days or less. The Company's money market fund instruments are categorized within Level 1 of the fair value hierarchy because they are valued using quoted market prices for identical instruments in active markets.
Summary of fair value on derivative instruments

Schedule of related party transactions
Related-Party Transactions with Total and its Affiliates:
 
 
Three Months Ended
(In thousands)
 
April 3, 2016
 
March 29, 2015
Revenue:
 
 
 
 
EPC, O&M, and components revenue under joint projects
 
$
40,927

 
$
755

Research and development expense:
 
 
 
 
Offsetting contributions received under the R&D Agreement
 
$

 
$
(422
)
Interest expense:
 
 
 
 
Guarantee fees incurred under the Credit Support Agreement
 
$
1,646

 
$
2,726

Interest expense incurred on the 0.75% debentures due 2018
 
$
375

 
$
375

Interest expense incurred on the 0.875% debentures due 2021
 
$
547

 
$
547

Interest expense incurred on the 4.00% debentures due 2023
 
$
1,000

 
n/a